You are here: Industry Insights > Drug

News List

US states file lawsuit against 20 drugmakers accused of price-fixing pharmaceutical-technology
May 14, 2019
An antitrust lawsuit filed by 44 US states has alleged that 20 pharmaceutical companies that make generic drugs have collaborated to fix prices and reduce market competition.
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs fiercepharma
May 13, 2019
After the FDA last year slapped a warning label on SGLT2 diabetes drugs, detailing risks of an infection with a rare fle
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder fda
May 13, 2019
The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.
Takeda to divest dry eye drug to Novartis in $5.3bn deal pharmaceutical-technology
May 10, 2019
Takeda Pharmaceutical has signed an agreement to sell its Xiidra 5% drug to Novartis for a total consideration of up to $5.3bn.
Generic Version of Truvada Available in U.S. by Sept. 2020 drugs
May 10, 2019
Generic Version of Truvada Available in U.S. by Sept. 2020.
New drug for Huntington lowers levels of disease-causing protein europeanpharmaceuticalreview
May 10, 2019
A new drug for Huntington disease is found to be safe and lowers levels of the abnormal protein that causes the debilitating disease in patients.
The price of access: Can the NHS afford Orkambi? pharmafile
May 09, 2019
The price of access: Can the NHS afford Orkambi?
Bicycle and DDF collaborate on drug development for CNS conditions pharmaceutical-technology
May 09, 2019
UK-headquartered Bicycle Therapeutics and venture capital fund Dementia Discovery Fund (DDF) have entered into a collaboration to use the former’s bicyclic peptide technology to identify new targets and development novel therapeutics for neurodegenerative
FDA approves paediatric LEMS drug pharmaceutical-technology
May 09, 2019
The US Food and Drug Administration (FDA) has approved Jacobus Pharmaceutical’s Ruzurgi (amifampridine) as a treatment for Lambert-Eaton myasthenic syndrome (LEMS).
New digital filter aims to improve chemical measurements europeanpharmaceuticalreview
May 09, 2019
A filter has been designed to create more exact measurements early in the drug development stage and help move a drug to clinical trials faster.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page